BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22133661)

  • 1. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users.
    Elaut E; Buysse A; De Sutter P; De Cuypere G; Gerris J; Deschepper E; T'Sjoen G
    Contraception; 2012 May; 85(5):470-9. PubMed ID: 22133661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Contraceptive Type on Sexual Desire of Women and of Men Partnered to Contraceptive Users.
    Mark KP; Leistner CE; Garcia JR
    J Sex Med; 2016 Sep; 13(9):1359-1368. PubMed ID: 27461964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sexuological impact of hormonal contraceptives based on their route of administration.
    Guida M; Di Carlo C; Troisi J; Gallo A; Cibarelli F; Martini E; Tiranini L; Nappi RE
    Gynecol Endocrinol; 2017 Mar; 33(3):218-222. PubMed ID: 27908210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of two types of hormonal contraception--oral versus intravaginal--on the sexual life of women and their partners.
    Guida M; Di Spiezio Sardo A; Bramante S; Sparice S; Acunzo G; Tommaselli GA; Di Carlo C; Pellicano M; Greco E; Nappi C
    Hum Reprod; 2005 Apr; 20(4):1100-6. PubMed ID: 15608030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol.
    Greco T; Graham CA; Bancroft J; Tanner A; Doll HA
    Contraception; 2007 Jul; 76(1):8-17. PubMed ID: 17586130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.
    Cagnacci A; Ferrari S; Tirelli A; Zanin R; Volpe A
    Contraception; 2009 Jul; 80(1):34-9. PubMed ID: 19501213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study.
    Fleischer K; van Vliet HA; Rosendaal FR; Rosing J; Tchaikovski S; Helmerhorst FM
    Thromb Res; 2009; 123(3):429-35. PubMed ID: 18829069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual function in first-time contraceptive ring and contraceptive patch users.
    Gracia CR; Sammel MD; Charlesworth S; Lin H; Barnhart KT; Creinin MD
    Fertil Steril; 2010 Jan; 93(1):21-8. PubMed ID: 18976753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended regimens of the vaginal contraceptive ring: cycle control.
    Guazzelli CA; Barreiros FA; Barbosa R; de Araújo FF; Moron AF
    Contraception; 2009 Nov; 80(5):430-5. PubMed ID: 19835716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cycle-Related Changes in Mood, Sexual Desire, and Sexual Activity in Oral Contraception-Using and Nonhormonal-Contraception-Using Couples.
    Elaut E; Buysse A; De Sutter P; Gerris J; De Cuypere G; T'Sjoen G
    J Sex Res; 2016; 53(1):125-36. PubMed ID: 25420716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive.
    Elkind-Hirsch KE; Darensbourg C; Ogden B; Ogden LF; Hindelang P
    Contraception; 2007 Nov; 76(5):348-56. PubMed ID: 17963858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
    Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.
    Massaro M; Di Carlo C; Gargano V; Formisano C; Bifulco G; Nappi C
    Contraception; 2010 Mar; 81(3):209-14. PubMed ID: 20159176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of two combined hormonal contraceptives with the same composition and different doses on female sexual function and plasma androgen levels.
    Strufaldi R; Pompei LM; Steiner ML; Cunha EP; Ferreira JA; Peixoto S; Fernandes CE
    Contraception; 2010 Aug; 82(2):147-54. PubMed ID: 20654755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contraceptive vaginal ring.
    Edwardson J; Jamshidi R
    Semin Reprod Med; 2010 Mar; 28(2):133-9. PubMed ID: 20352563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P; Dobay B; Wiita B
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose progestin-releasing contraceptives are associated with a higher pain threshold in healthy women.
    Máximo MM; Silva PS; Vieira CS; Gonçalvez TM; Rosa-E-Silva JC; Candido-Dos-Reis FJ; Nogueira AA; Poli-Neto OB
    Fertil Steril; 2015 Nov; 104(5):1182-9. PubMed ID: 26341277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism.
    Barreiros FA; Guazzelli CA; Barbosa R; Torloni MR; Barbieri M; Araujo FF
    Contraception; 2011 Aug; 84(2):155-9. PubMed ID: 21757057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database.
    Murphy PA; Brixner D
    Contraception; 2008 Apr; 77(4):257-63. PubMed ID: 18342648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Choosing contraception for adolescents].
    Wemeau-jacquemont C
    NPN Med; 1985 Feb; 5(84):185-9. PubMed ID: 12280585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.